Danaher (NYSE:DHR) Upgraded at Wall Street Zen

Danaher (NYSE:DHR) was upgraded by equities researchers at Wall Street Zen from a “hold” rating to a “buy” rating in a report issued on Sunday.

Several other analysts also recently weighed in on DHR. Redburn Partners set a $220.00 price objective on shares of Danaher in a research report on Wednesday, October 8th. Scotiabank upgraded shares of Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 price objective for the company in a research report on Friday, July 11th. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Danaher from $235.00 to $250.00 and gave the stock a “buy” rating in a research report on Wednesday, October 22nd. Wells Fargo & Company restated a “positive” rating on shares of Danaher in a research report on Thursday, October 23rd. Finally, Evercore ISI boosted their price objective on shares of Danaher from $226.00 to $245.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 7th. Eighteen analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $243.39.

Danaher Stock Up 0.3%

Shares of Danaher stock opened at $215.63 on Friday. Danaher has a 52-week low of $171.00 and a 52-week high of $258.23. The company has a 50 day moving average of $203.41 and a 200 day moving average of $199.54. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.33. The company has a market capitalization of $152.31 billion, a P/E ratio of 44.46, a P/E/G ratio of 3.28 and a beta of 0.77.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.72 by $0.17. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The company had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $6 billion. During the same quarter in the previous year, the firm earned $1.71 earnings per share. The firm’s quarterly revenue was up 4.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, research analysts forecast that Danaher will post 7.63 EPS for the current fiscal year.

Insider Activity at Danaher

In other news, Director Teri List sold 2,778 shares of Danaher stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the transaction, the director directly owned 20,751 shares of the company’s stock, valued at $4,379,706.06. The trade was a 11.81% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 11.10% of the stock is owned by insiders.

Hedge Funds Weigh In On Danaher

A number of institutional investors have recently modified their holdings of the business. Riverwater Partners LLC increased its holdings in shares of Danaher by 10.7% in the 3rd quarter. Riverwater Partners LLC now owns 5,156 shares of the conglomerate’s stock valued at $1,022,000 after acquiring an additional 498 shares during the period. Purkiss Capital Advisors LLC raised its position in Danaher by 3.9% during the 3rd quarter. Purkiss Capital Advisors LLC now owns 1,327 shares of the conglomerate’s stock worth $263,000 after buying an additional 50 shares during the last quarter. Vanguard Personalized Indexing Management LLC raised its position in Danaher by 1.9% during the 3rd quarter. Vanguard Personalized Indexing Management LLC now owns 69,937 shares of the conglomerate’s stock worth $13,868,000 after buying an additional 1,311 shares during the last quarter. AEGON ASSET MANAGEMENT UK Plc lifted its stake in shares of Danaher by 18.6% in the 3rd quarter. AEGON ASSET MANAGEMENT UK Plc now owns 181,218 shares of the conglomerate’s stock worth $35,897,000 after acquiring an additional 28,381 shares during the period. Finally, Cabot Wealth Management Inc. boosted its holdings in shares of Danaher by 7.4% in the third quarter. Cabot Wealth Management Inc. now owns 46,747 shares of the conglomerate’s stock valued at $9,268,000 after acquiring an additional 3,238 shares in the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.